Opaleye Management Inc. Harrow Health, Inc. Transaction History

Opaleye Management Inc.

$390 Million
Q2 2024

A detailed history of Opaleye Management Inc. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 3,990,000 shares of HROW stock, worth $152 Million. This represents 21.35% of its overall portfolio holdings.

Number of Shares

3,990,000

Previous 3,920,600 1.77%

Holding current value

$152 Million

Previous $51.9 Million 60.7%

% of portfolio

21.35%

Previous 12.62%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.0 - $21.64 $694,000 - $1.5 Million	69,400 Added 1.77%	3,990,000 $83.4 Million
Q1 2024 May 15, 2024	BUY	$9.3 - $13.23 $935,580 - $1.33 Million	100,600 Added 2.63%	3,920,600 $51.9 Million
Q4 2023 Feb 14, 2024	BUY	$8.1 - $16.36 $202,500 - $409,000	25,000 Added 0.66%	3,820,000 $42.8 Million
Q3 2023 Nov 14, 2023	BUY	$14.03 - $22.08 $280,600 - $441,599	20,000 Added 0.53%	3,795,000 $54.5 Million
Q4 2022 Feb 10, 2023	BUY	$10.28 - $14.78 $4.43 Million - $6.37 Million	431,183 Added 12.89%	3,775,000 $55.7 Million
Q3 2022 Nov 14, 2022	BUY	$6.57 - $24.88 $72,828 - $275,794	11,085 Added 0.33%	3,343,817 $40.4 Million
Q2 2022 Aug 15, 2022	BUY	$5.75 - $7.74 $237,986 - $320,350	41,389 Added 1.26%	3,332,732 $24.3 Million
Q1 2022 May 16, 2022	BUY	$6.77 - $8.66 $42,942 - $54,930	6,343 Added 0.19%	3,291,343 $22.4 Million
Q3 2021 Nov 16, 2021	BUY	$6.99 - $10.6 $1.01 Million - $1.54 Million	145,000 Added 4.62%	3,285,000 $29.9 Million
Q2 2021 Aug 16, 2021	BUY	$6.68 - $11.07 $498,221 - $825,644	74,584 Added 2.43%	3,140,000 $29.2 Million
Q4 2020 Feb 12, 2021	BUY	$4.76 - $6.93 $506,540 - $737,462	106,416 Added 3.6%	3,065,416 $21 Million
Q3 2020 Nov 16, 2020	BUY	$4.71 - $7.36 $1.17 Million - $1.83 Million	249,000 Added 9.19%	2,959,000 $16.5 Million
Q2 2020 Aug 14, 2020	BUY	$3.61 - $6.47 $9.78 Million - $17.5 Million	2,710,000 New	2,710,000 $14.1 Million

Others Institutions Holding HROW

# of Institutions

122

Shares Held

19.7M

Call Options Held

700K

Put Options Held

575K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.03B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Account

Opaleye Management Inc. Harrow Health, Inc. Transaction History